The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

28 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Chemoenzymatic synthesis and binding affinity of novel (R)- and (S)-3-aminomethyl-1-tetralones, potential atypical antipsychotics.EBI
Universidad De Santiago De Compostela
Potent and selective MAO-B inhibitory activity: amino- versus nitro-3-arylcoumarin derivatives.EBI
Universidad De Santiago De Compostela
Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands.EBI
Universidad De Santiago De Compostela
Synthesis and binding affinity of new 1,4-disubstituted triazoles as potential dopamine D(3) receptor ligands.EBI
Universidad De Santiago De Compostela
Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif.EBI
Universidad De Santiago De Compostela
Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics.EBI
Universidad De Santiago De Compostela
Butyrophenone analogues in the carbazole series: synthesis and determination of affinities at D2 and 5-HT2A receptors.EBI
Universidad De Santiago De Compostela
Synthesis and biological evaluation of 1a,25-dihydroxyvitamin D3 analogues with a long side chain at C12 and short C17 side chains.EBI
Universidad De Santiago De Compostela
On a possible neutral charge state for the catalytic dyad inß-secretase when bound to hydroxyethylene transition state analogue inhibitors.EBI
Universidad De Santiago De Compostela
A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors.EBI
Universidad De Santiago De Compostela
MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.EBI
Universidad De Santiago De Compostela
New halogenated phenylcoumarins as tyrosinase inhibitors.EBI
Universidad De Santiago De Compostela
New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors.EBI
Universidad De Santiago De Compostela
Synthesis and biological evaluation of new nanomolar competitive inhibitors of Helicobacter pylori type II dehydroquinase. Structural details of the role of the aromatic moieties with essential residues.EBI
Universidad De Santiago De Compostela
Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.EBI
Universidad De Santiago De Compostela
Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.EBI
Universidad De Santiago De Compostela
6-N,N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides.EBI
Universidad De Santiago De Compostela
Pyridazines part 41: synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl)pyridazin-3(2H)-ones.EBI
Universidad De Santiago De Compostela
Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids.EBI
Universidad De Santiago De Compostela
Ligand recognition by RAR and RXR receptors: binding and selectivity.EBI
Universidad De Santiago De Compostela
Structure-based design, synthesis, and biological evaluation of inhibitors of Mycobacterium tuberculosis type II dehydroquinase.EBI
Universidad De Santiago De Compostela
Parallel solid-phase synthesis and evaluation of inhibitors of Streptomyces coelicolor type II dehydroquinase.EBI
Universidad De Santiago De Compostela
1-(2'-Bromobenzyl)-6,7-dihydroxy-EBI
Universidad De Santiago De Compostela
Exploring the water-binding pocket of the type II dehydroquinase enzyme in the structure-based design of inhibitors.EBI
Universidad De Santiago De Compostela
Experimental and 'in silico' analysis of the effect of pH on HIV-1 protease inhibitor affinity: implications for the charge state of the protein ionogenic groups.EBI
Universidad De Santiago De Compostela
Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics.EBI
Universidad De Santiago De Compostela
25 S-Adamantyl-23-yne-26,27-dinor-1α,25-dihydroxyvitamin DEBI
Universidad De Santiago De Compostela
Aminoquinazoline compounds as A2A antagonistBDB
Merck Sharp & Dohme